The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

Panel A shows dereplicated reads from wastewater virome sequencing assigned to H5N1 from all samples with a validated H5N1 signal aligned to a recently collected H5N1 2.3.4.4b reference sequence ...

It’s now up to the Senate to consider how the entrenched monopolist in genomic sequencing in the U.S ... reference to the sequencing giant Illumina. WuXi AppTec earlier told C&EN that it ...

Gene sequencing company Illumina took a legal gamble in the summer of 2021, closing on its purchase of Grail, a former business unit it spun off in 2016, before European competition regulators had ...

On September 3, 2024, the EU’s highest court, the European Court of Justice (ECJ), ruled that the European Commission (EC) had no jurisdiction to review Illumina’s acquisition of Grail ...

San Diego gene-sequencing pioneer Illumina on Tuesday won its court fight against the European Union’s investigation of its $7.1 billion purchase of cancer diagnostic test maker Grail ...

Though Illumina said goodbye to Grail this past ... of Grail could tempt it to wield its massive market share in DNA sequencing, and throttle back the research of its rivals in cancer screening.

Menlo Park, California-based Grail was spun off from DNA sequencing giant Illumina in 2016 to develop a blood test to detect 50 types of early stages of cancer. San Diego-based Illumina sought to ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...